5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients

MLA

Mario Occhipinti, et al. “5-Fluorouracil Degradation Rate (5-FU-DR) as a New Toxicity Predictive Biomarker for Adjuvant FOLFOX in Colorectal Cancer (CRC) Patients.” Annals of Oncology, vol. 27, Oct. 2016, p. vi195. EBSCOhost, https://doi.org/10.1093/annonc/mdw370.134.

APA

Mario Occhipinti, F.R. Di Pietro, Adriana Romiti, Federica Mazzuca, Rosa Falcone, A. Botticelli, Annalisa Milano, Luana Lionetto, Piero Marchetti, Michela Roberto, Maurizio Simmaco, & Concetta Elisa Onesti. (2016). 5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients. Annals of Oncology, 27, vi195. https://doi.org/10.1093/annonc/mdw370.134

Chicago

Mario Occhipinti, F.R. Di Pietro, Adriana Romiti, Federica Mazzuca, Rosa Falcone, A. Botticelli, Annalisa Milano, et al. 2016. “5-Fluorouracil Degradation Rate (5-FU-DR) as a New Toxicity Predictive Biomarker for Adjuvant FOLFOX in Colorectal Cancer (CRC) Patients.” Annals of Oncology 27 (October): vi195. doi:10.1093/annonc/mdw370.134.